Skip to content

Prospective, Multicenter Registry of Patients with Previous Disability Receiving Endovascular Treatment Acute Ischemic Stroke

Prospective, Multicenter Registry of Patients with Previous Disability Receiving Endovascular Treatment Acute Ischemic Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111791
Enrollment
Unknown
Registered
2025-11-05
Start date
2025-11-15
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Standard medication group:None
EVT combined with standard medical therapy group:None

Sponsors

The Second Affiliated Hospital of the Army Medical University PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1.Patients with acute anterior circulation occlusion or posterior circulation occlusion (intracranial segment of internal carotid artery, M1-M3 segment of middle cerebral artery, A1-A3 segment of anterior cerebral artery, V4 segment of vertebral artery, P1-P3 segment of basilar artery and posterior cerebral artery); 2.Preoperative mild or above dysfunction (MRS>= 2) lasting for at least 3 months; 3.Written informed consent signed by patients or family members; 4.18 <= age <= 120.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.The symptoms and signs were aggravated after the first stroke, and the diagnosis was progressive stroke; 3.Intracranial hemorrhage confirmed by computed tomography (CT) or magnetic resonance imaging (MRI); 4.Researchers judged that the duration of disability before stroke was too short; 5.Expected failure to complete follow-up; 6.Midline displacement of brain due to cerebral hernia; 7.Other clinical trials currently involved will affect the results of this study.

Design outcomes

Primary

MeasureTime frame
SICH within 48h;Proportion of patients with functional recovery at 90 days (i.e., 90-day mRS score not increased compared to pre-stroke mRS score);90 day mortality;Any intracranial hemorrhage within 48h;;Score distribution with Mrs score of 0-3, 4, 5 or 6 at 90 days;

Secondary

MeasureTime frame
The change in modified Rankin Scale (?mRS) from baseline to 90 days (ranging from -2, -1, 0, 1, 2, 3, 4, 5, 6 on the ordinal scale).;Changes in NIHSS scores at 5-7 days or early discharge;Recanalization rate ((mtici = 2b);Percentage of patients with 90-day mRS score of 0-2;Expanded (eTICI) scores (only in EVT group);Percentage of patients with 90-day mRS score of 0-3;Percentage of patients with 90-day mRS score of 0-1;Distribution of 90-day mRS scores;

Countries

China

Contacts

Public ContactWenjie Zi

The Second Affiliated Hospital of the Army Medical University PLA

ziwenjie@126.com+86 18523033816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026